On Invalid Date, Viatris (NASDAQ: VTRS) reported Q2 2023 earnings per share (EPS) of $0.22, up 15.38% year over year. Total Viatris earnings for the quarter were $264.00 million. In the same quarter last year, Viatris's earnings per share (EPS) was $0.26.
As of Q3 2023, Viatris's earnings has grown 142.86% year over year. This is 80.18 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 62.68%. Viatris's earnings in the past year totalled $1.85 billion.
What is VTRS's earnings date?
Viatris's earnings date is Invalid Date. Add VTRS to your watchlist to be reminded of VTRS's next earnings announcement.
What was VTRS's revenue last quarter?
On Invalid Date, Viatris (NASDAQ: VTRS) reported Q2 2023 revenue of $3.92 billion up 4.81% year over year. In the same quarter last year, Viatris's revenue was $4.12 billion.
What was VTRS's revenue growth in the past year?
As of Q3 2023, Viatris's revenue has grown -9.22% year over year. This is 19.9 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.68%. Viatris's revenue in the past year totalled $15.60 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.